Cargando…
Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic sympto...
Autores principales: | Yui, Kunio, Imataka, George, Sasaki, Hitomi, Kawasaki, Yohei, Okanshi, Tohru, Shiroki, Ryoichi, Yoshihara, Shigemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907049/ https://www.ncbi.nlm.nih.gov/pubmed/31871809 http://dx.doi.org/10.1155/2019/2070619 |
Ejemplares similares
-
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
por: Imataka, George, et al.
Publicado: (2021) -
Contribution of Transferrin and Ceruloplasmin Neurotransmission and Oxidant/Antioxidant Status to the Effects of Everolimus: A Case Series
por: Yui, Kunio, et al.
Publicado: (2020) -
Lipid Peroxidation With Implication of Organic Pollution in Autistic Behaviors
por: Yui, Kunio, et al.
Publicado: (2021) -
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder
por: Yui, Kunio, et al.
Publicado: (2022) -
Everolimus dosing recommendations for tuberous sclerosis complex–associated refractory seizures
por: Franz, David N., et al.
Publicado: (2018)